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Abstract
Introduction and hypothesis The aim of this study was to
compare outcome and quality of life of tension-free vaginal
tape “inside-out” (TVT-O) and Monarc transobturator tapes
after 2–4 years.
Methods The method used was a prospective comparative
study. Participants (n=191) were assigned to either a TVT-O
(n=93) or a Monarc (n=98) procedure. Cure of stress urinary
incontinence (SUI) was defined as the statement of the woman
of not experiencing any loss of urine upon physical exercise.
Results Cure rates after 2–4 years were 72% for TVT-O
and 65% for Monarc, while improvement was observed in,
respectively, 12% and 21% (p=0.3). There was a statisti-
cally significant improvement in quality of life but no
differences were found between both procedures.
Conclusions After a 2–4-year follow-up period, both
procedures were equally safe and effective in curing SUI.
Keywords Monarc.Stressurinaryincontinence.
Transobturatortape.TVT-O
Introduction
Until recently, the Burch colposuspension was the standard
procedure for the treatment of female stress urinary
incontinence (SUI) [1, 2]. Since its introduction in 1995,
tension-free vaginal tape (TVT) became the new “gold”
standard in the surgical treatment of SUI. TVT has been
proven to be as effective as the Burch colposuspension with
success rates ranging from 84% to 95%, but has less side
effects and complications [3-5]. In 2001, Delorme intro-
duced transobturator tape (TOT) with a high success rate
[6]. This sling is also located underneath the mid-urethra,
but runs laterally through the obturator membrane to the
upper part of the thigh.
There are two basic techniques for performing TOT:
“outside-in” described by Delorme [6]a n d“inside-out”
(TVT-O) described by de Leval [7]. These techniques differ
not only in the way the needle is placed and carried forward
but also in the different designs of the introducer. After the
introduction of the outside-in technique by Delorme in
2001, several other similar procedures were developed.
Among them is Monarc, which consists like TVT-O of a
monofilament macroporous polypropylene mesh and which
has shown similar and equally good short- to medium-term
success rates as TVT-O [8, 9].
However, until now, there is little evidence that one
technique is superior to the other. Furthermore, no
comparative trials are published with follow-up longer than
1 year. Therefore, the aim of this study is to compare the
outcome and the quality of life results of two existing
different TOT procedures inside-out (TVT-O) and outside-
in (Monarc) for the treatment of SUI after a 2–4-year
follow-up.
Materials and methods
Between October 2004 and December 2006, 191 consec-
utive women with an indication for surgical treatment of
SUI underwent either the TVT-O or the Monarc procedure.
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Included were 93 women with a TVT-O and 98 women
with a Monarc procedure. Women who did not show up for
their 2–4-year follow-up visit first received a questionnaire
and, if they did not reply, were later contacted by one of the
investigators (MH).
Excluded were women with recurrent and difficult to
treat urinary tract infections, significant and predominantly
symptoms of urge urinary incontinence, post voiding
bladder retention of more than 150 ml, bladder capacity
of less than 100 ml, and physical or mental impairment to
adequately register outcome results or complications.
A standardized urogynecological history and physical
examination was performed preoperative, after 2 months,
1 year, and after 2 to 4 years. Preoperative multichannel
urodynamic investigation was carried in all women according
to the International Continence Society standards [10, 11].
All women were asked to complete the short version of
the Incontinence Impact Questionnaire (IIQ-7) and the
Urogenital Distress Inventory (UDI-6) before and at the
above-mentioned postoperative intervals. These question-
naires are internationally accepted as valid disease-specific
quality of life (QoL) instruments and are sensitive to
change [12]. They have been translated into Dutch
language and validated [13]. The questionnaires were
anonymously entered in a database, and researchers were
blinded to the individual results of these questionnaires. The
total score of the IIQ-7 and UDI-6 was transformed to a
scale from 0 to 100 (a higher score indicates more bother).
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procedure just before surgery was to take place. The inside-out
procedure was performed as described by de Leval [7], and a
TVT-O (Gynecare, Sommerville, NJ, USA) tape was inserted.
The Monarc (American Medical Systems, Minneapolis, MN,
USA) tape was inserted through the outside-in route as using the
technique recommended by the manufacturer. Both procedures
use a monofilament, macroporous polypropylene tape, which is
placed under the urethra without any tension. Surgery was not
accompanied by other urogynecological procedures.
All procedures were carried out under general anesthesia, and
hence, no intra-operative cough stress test was performed.
Cystoscopy was performed only in case of encountering bloody
urine. All women received preoperative antibiotics, and this was
continued for 7 days postoperative. All procedures were
performedintheSt.ElisabethHospitalTilburg,TheNetherlands.
We adhered to the recommendations of IUGA on outcome
measures[14]. Cure of SUI was defined as the statement of the
woman of not experiencing any loss of urine upon physical
exercise. Other definitions in this study are in accordance with
the terminology of the International Continence Society [10].
Continuous variables were compared using unpaired t
test, and dichotomous variables were compared using chi-
square test. Fisher’s exact test was used if cross tabs had a
cell with an expected frequency <5. The minimum level of
significance was 0.05. Statistical analyses were performed
with SPSS (Windows version 16.0).
Results
After a 2–4-year follow-up, 161 (84%) women were
available for evaluation. The TVT-O group consisted of
75 women compared to 86 women in the Monarc group.
The mean follow-up of the TVT-O group was 38 months
(range 12–53 months) and 39 months (range 12–53 months)
in the Monarc group. For their 2–4-year follow-up control,
76 (47%) women visited our outpatient department, 51
(32%) women answered a questionnaire by mail, and 34
(21%) women answered a telephonic questionnaire by one
of the investigators (MH). The response rate of the QoL
questionnaires was 92%, 81%, 81%, and 70% respectively
prior to, 2 months and 1 year postoperatively, and after 2–
4 years. There were no differences in method of follow-up or
response rate of QoL questionnaires between both groups.
Preoperative data are listed in Table 1. No differences
between both groups were observed. In women with mixed
urinary incontinence (MUI), anti-cholinergic medical treat-
ment was given before surgical treatment was considered and
did not alleviate their symptoms. The majority (89%) of the
women underwent preoperative pelvic floor physiotherapy.
Surgical data are depicted in Table 2. No concomitant
urogynecological surgery was performed, but in 15 women
(8%), surgery was combined with non-urogynecological
procedures. There are no differences in surgery time,
amount of blood loss, and type of anesthesia between
TVT-O and Monarc.
Outcome data are presented in Table 3. The cure rate for
TVT-O was 72% after 2–4 years compared to 65% in the
Monarc group, while improvement was observed in
respectively 12% and 21% (p=0.3). Preexisting urge
incontinence resolved in seven women (32%) after TVT-O
and eight women (31%) after Monarc (p=1.0). De novo
urge incontinence developed in two cases in the TVT-O
group versus four cases in the Monarc group (p=0.2).
Both the IIQ-7 and UDI-6 demonstrated a statistically
significant increase in QoL decrease in impairment caused
by symptoms of SUI after 2 months, 1 year, and 2–4 years
in both TOT groups.
Any complications are presented in Table 4. No major
intra-operative complications occurred. After 2 months,
voiding difficulty was more observed in the TVT-O group.
Tape release was carried out in one woman in the TVT-O
group because of vaginal pain and a superficial located and
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tape release was indicated for voiding difficulty. Afterward,
voiding became normal and they remained continent.
There were five cases of vaginal erosion, which were all
excised under local anesthesia, and all remained continent
afterward. In five women after TVT-O and in four women
after Monarc, a second anti-incontinence procedure was
performed (p=0.5). As second incontinence procedures,
tension-free vaginal tape (seven times), tension-free vaginal
tape Secur (once), and Remeex system (once) were
performed. The stress incontinence was resolved in all nine
women. In one other woman, a stitch was placed under the
TVT-O Monarc p value
Length of surgery (min; mean ± SD, range) 16±5 [10–34] 16±6 [10–30] 0.9
a
Amount of blood loss (ml; mean ± SD, range) 55±53 [0–300] 62±42 [0–250] 0.3
a
Type of anesthesia (n,% )
General 85 (91%) 84 (86%) 0.2
b
Spinal 8 (9%) 14 (14%)
Simultaneous performed secondary surgical procedure
Hysteroscopic endometrial ablation/myoma resection 2 2
Introital plasty 2
Sterilization 4 2
LLETZ 1
Cystoscopic resection of bladder endometiosis 1
Inguinal hernia repair 1
Table 2 Surgery characteristics
aStudent t test (two-sided)
bChi-square test
TVT-O Monarc p value
Number of women (n, %) 93 (49%) 98 (51%)
Medical history
Age (years, mean ± SD) 49.2±8.9 49.5±10.3 0.8
a
Type of incontinence (n,% )
SUI 74 (80%) 74 (76%)
MUI 19 (20%) 23 (24%) 0.6
b
Parity (number of vaginal deliveries; mean, SD) 2±1 2±1 0.8
a
Multiparous (n, %) 84 (90%) 92 (94%) 0.7
c
Menopausal status (n,% )
Premenopausal 51 (55%) 58 (59%)
Climacterial 9 (10%) 6 (6%) 0.5
b
Postmenopausal 33 (35%) 34 (35%)
Severity of incontinence (daily episodes; n, %) 79 (85%) 79 (81%) 0.6
b
Pelvic floor physiotherapy prior to surgery (n,% )
Performed 82 (88%) 88 (90%) 0.5
c
Previous incontinence surgery 8 (9%) 9 (9%) 1.0
b
Previous prolapse surgery 19 (22%) 15 (16%) 0.3
b
Physical examination
Urethral hypermobility (n, %) 80 (86%) 90 (92%) 0.3
b
Urinary incontinence on coughing (n, %) 62 (67%) 67 (68%) 1.0
b
Vaginal wall prolapse (grade 1 or more; n, %) 25 (27%) 24 (24%) 0.7
b
Urodynamic investigation
Maximum bladder capacity (ml, mean ± SD) 443±121 433±130 0.6
a
Number of women with urodynamic SUI (n, %) 61 (66%) 64 (65%) 0.9
b
Number of women with detrusor overactivity (n, %) 5 (6%) 7 (7%) 0.7
b
Maximum urethral closure pressure (cm H2O, mean±SD) 59±31 64±43 0.5
a
Number of women with MUCP<20 cm H2O( n, %) 5 (5%) 1 (1%) 0.1
c
Table 1 Preoperative data
aStudents t test (two-sided)
bChi-square test
cFisher’s exact test
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improved SUI disappeared.
Discussion
This report comprises a large comparative study of both
procedures with the longest follow-up until now. The main
objective of this study was to compare outcome and
complications for an inside-out versus an outside-in trans-
obturator approach. The second objective was to evaluate
results of both obturator approaches after a 2–4-year
follow-up. We did not find significant differences between
both approaches. Approximately 85% of the women found
their symptoms to be improved after 2–4 years, which are
satisfying results.
Most studies comparing TVT-O and Monarc have a
short follow-up time and differ with respect to definitions
of success. Debodinance compared 50 TVT-O procedures
to 50 Monarc procedures in a prospective observational
Table 3 Outcome of TVT-O and Monarc procedures
TVT-O p value within
TVT-O group
Monarc p value within
Monarc group
p value between
groups
Stress urinary incontinence (SUI)
2 months after surgery
No SUI 76 (85%) 78 (83%)
Improved 7 (9%) 12 (13%) 0.4
a
Unchanged 6 (7%) 4 (4%)
12 months after surgery
No SUI 66 (77%) 73 (77%)
Improved 13 (15%) 16 (17%) 0.9
b
Unchanged 7 (8%) 6 (6%)
2–4 years after surgery
No SUI 54 (72%) 56 (65%)
Improved 9 (12%) 18 (21%) 0.3
b
Unchanged 12 (16%) 12 (14%)
Quality of life analysis
Incontinence Impact Questionnaire (IIQ-7, mean ± SD)
Prior to surgery 56±21 51±22 0.1
c
2 months after surgery 11±20 0.0
d 13±21 0.0
d 0.6
c
12 months after surgery 13±21 0.0
d 11±19 0.0
d 0.7
c
2–4 years after surgery 11±28 0.0
d 12±20 0.0
d 0.6
c
Urodynamic Distress Inventory (UDI-6, mean ± SD)
Prior to surgery 45±17 45±16 0.7
c
2 months after surgery 17±18 0.0
d 16±17 0.0
d 0.7
c
12 months after surgery 16±20 0.0
d 16±17 0.0
d 0.9
c
2–4 years after surgery 17±18 0.0
d 17±17 0.0
d 1.0
c
Urge urinary incontinence (UUI)
Prior to surgery present 22 (24%) 26 (26%) 0.7
b
UUI resolved, 2 months after surgery 12 (55%) 14 (54%) 0.7
b
UUI resolved, 12 months after surgery 13 (59%) 17 (65%) 0.5
b
UUI resolved, 2–4 years after surgery 7 (32%) 8 (31%) 1.0
b
Prior to surgery absent
De novo UUI, 2 months after surgery 0 2 (4%) 0.5
a
De novo UUI, 12 months after surgery 3 (4%) 6 (6%) 0.5
a
De novo UUI, 2–4 years after surgery 2 (3%) 4 (5%) 0.2
a
aFisher’s exact test
bChi-square test; statistically significant differences are in bold
cStudent t test (two-sided)
dWilcoxon signed ranks test, pre- compared to postoperative situation within one group
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postoperative urodynamic assessment, 47 (94%) women
with TVT-O and 45 (90%) with Monarc were cured after
1 year. Lee et al. prospectively compared 100 women who
underwent either a TVT-O (n=50) or a TOT (Dow Medics,
Korea, n=50) procedure and defined cure as a negative
cough stress test and no reports of urine leakage during
stress [16]. Equal cure rates for TVT-O and TOT were
found: 86% versus 92% 1 year after surgery. Liapsis et al.
followed up 114 women who were prospectively random-
ized to TVT-O or Monarc for 1 year [17]. Cure was defined
as a negative cough stress test during multichannel
urodynamic investigation and a 1-h pad test giving a
weight of less than 1 g. Cure rate in the TVT-O group was
87% (53 of 61 women) and 90% (48 of 53 women) in the
Monarc group. Subjective cure was remarkably lower: 80%
in the TVT-O group versus 77% in the Monarc group.
Not many studies have investigated the medium-term
results (>1 year) of obturator tapes. Waltregny et al.
followed up 91 women prospectively after a TVT-O
procedure with a minimum follow-up of 3 years [18]. Cure
of SUI was defined by the disappearance of subjective SUI,
as assessed by a SUI symptom scale score equal to 0.
Disappearance and improvement of SUI was observed in
88% and 9% of the women, respectively. Wang et al. found
an 83% cure rate 36 months after a TVT-O procedure. The
clinical outcome was regarded as cured when the cough test
was negative at the follow-up visit. Their results were based
on 30 women with a 36-month follow-up.
The above-mentioned comparative studies show as
presented in this study that both TVT-O and Monarc are
equally effective in curing SUI after 1 year [15-17]. On
longer follow-up, our results are lower compared to the
mentioned studies [18, 19]. This might be due to our
definition of cure. We intentionally used the statement of
women about losing urine upon physical exercise. Al-
though this is a subjective parameter, it does give
information about the experience of women over a longer
period of time. This may provide more or different
information than objective parameters like a postoperative
stress test, pad test, or urodynamic investigation, which just
reflect a measurement at one point in time. We realize
however that in a small number of women it is quite
possible that “failures” are actually reporting the symptom
of urge incontinence rather than the diagnosis of genuine
stress incontinence. To demonstrate this difference, objec-
tive testing would be required.
Our strict definition of success, being no loss of urine at
all, may be unrealistic compared to the occurrence of
incontinence and experience of women in the normal
population. Becoming fully continent after TVT is not
synonymous with being satisfied. A number of operated
women still leaked postoperatively but were satisfied.
These were mostly women with severe incontinence who
experienced substantial improvement, the incontinence
being reduced to an acceptable degree. This corroborates
the finding that women can cope with a certain degree of
incontinence for which therapy is not warranted [20].
However, for scientific purposes, it is perhaps better and
gives accurate insight in cure and improvement rates. For
counseling purposes to women, the improvement rate is
also of importance. In our study with a long follow-up of 2
to 4 years, 72% of women with a TVT-O were cured and
another 12% improved, while in the Monarc group, these
numbers are, respectively, 65% and 21%. This indicates
that most women are still much better off after these
incontinence procedures.
In determining success, another important parameter is
the improvement in quality of life. In our study, QoL
parameters improved significantly in both groups, and no
differences were found between the two procedures. In
general, the improvement observed after both procedures
seems comparable to QoL improvement after a TVT
procedure [3].
Table 4 Complications and second incontinence procedures
TVT-O Monarc p value
Intra-operative complications (n,% )
Bleeding>100 ml
a 4 (4%) 5 (5%) 0.9
b
Fausse route (within vagina) 1 (1%) 1 (1%) 0.6
b
Second TOT procedure
c 0 1 (1%) 1.0
b
Postoperative complications 2 months (n,% )
Voiding difficulty 10 (12%) 3 (3%) 0.03
b
Vaginal erosion 0 1 (1%) 1.0
b
Postoperative complications 12 months (n,% )
Voiding difficulty 4 (5%) 3 (4%) 0.7
b
Vaginal erosion 1 (1%) 3 (3%) 0.6
b
Tape release 1 (1%) 1 (1%) 1.0
b
Dyspareunia 1 (1%) 1 (1%) 1.0
b
Persisting pain in thigh 0 2 (2%) 0.5
b
Postoperative complications 2–4 years (n,% )
Voiding difficulty 3 (4%) 5 (6%) 0.7
b
Vaginal erosion
d 1 (1%) 4 (5%) 0.4
b
Dyspareunia 1 (1%) 0 1.0
b
Persisting pain in thigh 0 1 (1%) 1.0
b
Second incontinence procedures (n,% )
<1 year after primary procedure 3 (4%) 3 (4%)
>1 year after primary procedure 2 (2%) 1 (1%)
Total 5 (6%) 4 (5%) 0.5
b
aRange 150–300
bFisher’s exact test
cSecond procedure performed within the same surgery session due to
accidently premature cutting of the tape
dTotal erosions after a 2–4-year follow-up
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of de novo urge incontinence and voiding difficulty or the
resolution of these symptoms. The risk for developing de
novo urge incontinence seems to be equal after Monarc and
TVT-O procedures. This observation is confirmed by the
other comparative studies [15-17]. The number of women
reporting voiding difficulty after 2 months is higher in the
TVT-O group. There is no explanation for this difference.
Latthe’s results [21] indicate that voiding difficulty was less
for combined TVT-O and TOT tapes compared to the
retropubic TVT procedure. On subgroup analysis, they
found no differences between the procedures by either
obturator route.
Anatomical complications like bladder or urethra injury
or bleeding of more than 300 ml did not occur in this study.
Furthermore, the three remaining complications in this
study (two accidental fausse routes and one premature
cutting of the tape) are relative minor incidents. Both TVT-O
and Monarc have substantial lower intra-operative compli-
cation rates than TVT, but no differences between both
procedures are observed [21].
When TVT-O and Monarc became available, there was
some evidence that one procedure could be less safe than
the other. Achtari et al. [22] showed by cadaveric dissection
that TVT-O runs more closely to the obturator canal,
making TVT-O more prone to possible injury of the
obturator nerve and vessels. We did not find any obturator
nerve or vessel injury, and apparently, this theoretical risk
does not exist in clinical practice.
Although the number of women is too small to draw
conclusions, there seems to be a little higher erosion rate in the
Monarc group. These results are confirmed by other publica-
tions but a significant difference was never reached, mostly
due small patient numbers [21]. Nevertheless, the postopera-
tive complication rate in our study population is low, and no
differences between both procedures were observed.
Advantages of this study are the large number of women
with only 16% loss to follow-up after 2–4 years. Other
advantages are a strict outcome parameter, a consistent
treatment strategy where procedures were not combined
with other urogynecological treatments, the standardized
urogynecological work-up (including urodynamic investi-
gation), and the fact that all women were treated in one
clinic by two urogynecologists and residents (always with
supervision and the presence of these urogynecologist
during surgery).
The draw-back of this study may be the bias in follow-
up results. Not all women visited our outpatient department
for the follow-up procedure. There may be a difference in
the results of women visiting our outpatient department
compared to women answering questionnaires by mail or
telephone. Nevertheless, the use of interviews by telephone
allowed us to minimize the loss to follow-up.
This study shows equal clinical cure rates and improve-
ment in quality of life for both TVT-O and Monarc as a
surgical treatment for stress urinary incontinence on the
long run. Nevertheless, while longer follow-up data of TVT
are now available [23], longer follow-up than 4 years is still
mandatory.
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